Nancy Stuart
Officer at Concert Pharmaceuticals, Inc. (CNCE)
Nancy Stuart has filed 13 insider reports with the SEC since February 2021, as director at KalVista Pharmaceuticals, Inc. (KALV) and officer at Concert Pharmaceuticals, Inc. (CNCE). Nancy Stuart made no open-market purchases or sales in the last 12 months. The latest filing, on October 2, 2025, reports grant or award at KalVista Pharmaceuticals, Inc. (KALV).
- Filings
- 13
- Companies
- 2
- Bought on market
- None
- Sold on market
- $254K
Companies where Nancy Stuart is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince March 2021 | Oct 2, 2025 | ||||||
| Officer | 262,596 | $254K | Feb 16, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Oct 1, 2025KALVSEC Form 4 filed by Director Stuart NancyForm 4Grant or award
- Oct 3, 2024KALVSEC Form 4 filed by Director Stuart NancyForm 4Grant or award
- Sep 26, 2023KALVSEC Form 4 filed by Stuart NancyForm 4Grant or award
- Feb 15, 2023-$50.4KCNCESEC Form 4: Stuart Nancy sold $50,380 worth of shares (6,048 units at $8.33) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 262,596 units (withholding obligation)Form 4Open-market sale10b5-1 plan
- Jan 30, 2023-$110KCNCESEC Form 4: Stuart Nancy sold $110,220 worth of shares (13,200 units at $8.35) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 268,644 units (withholding tax)Form 4Open-market sale10b5-1 plan
- Jan 6, 2023-$21KCNCESEC Form 4: Stuart Nancy sold $20,974 worth of shares (2,893 units at $7.25) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 281,844 units (for withholding tax)Form 4Open-market sale10b5-1 plan
- Oct 13, 2022KALVSEC Form 4 filed by Stuart NancyForm 4Grant or award
- Feb 14, 2022-$18.6KCNCESEC Form 4: Stuart Nancy sold $18,631 worth of shares (6,049 units at $3.08) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 284,737 units (tax withholding)Form 4Open-market sale10b5-1 plan
- Jan 28, 2022CNCESEC Form 4: Stuart Nancy was granted 120,400 shares, increasing direct ownership by 71% to 290,786 unitsForm 4Grant or award
- Jan 5, 2022-$9,232CNCESEC Form 4: Stuart Nancy sold $9,232 worth of shares (2,894 units at $3.19) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 170,386 units (for withholding tax)Form 4Open-market sale10b5-1 plan
- Mar 18, 2021KALVSEC Form 4 filed by Nancy StuartForm 4Grant or award
- Mar 18, 2021KALVSEC Form 3 filed by Nancy StuartForm 3New insider
- Feb 16, 2021-$44.3KCNCESEC Form 4: Nancy Stuart sold $44,279 worth of Common Stock (6,049 units at $7.32), decreasing ownership by 3% to 173,280 unitsForm 4Open-market sale10b5-1 plan
Compare Nancy Stuart with
- Nancy Stuart vs Christopher Yea1 shared
- Nancy Stuart vs Nicole Sweeny1 shared
- Nancy Stuart vs Paul K. Audhya1 shared
- Nancy Stuart vs Benjamin L Palleiko1 shared
- Nancy Stuart vs Brian Piekos1 shared
- Nancy Stuart vs Bilal Arif1 shared
Other insiders at the same companies
- Christopher YeaKALV
- Paul K. AudhyaKALV
- Nicole SweenyKALV
- Benjamin L PalleikoKALV
- Brian PiekosKALV
- Venrock Healthcare Capital Partners III, L.P.KALV
- Bilal ArifKALV
- Brian JG PereiraKALV
- Patrick TreanorKALV
- William FaireyKALV
- Edward W UnkartKALV
- Bethany SensenigKALV
- Laurence ReidKALV
Questions about Nancy Stuart
- What is Nancy Stuart's role at Concert Pharmaceuticals, Inc.?
- Nancy Stuart reports to the SEC as officer at Concert Pharmaceuticals, Inc. (CNCE), according to the latest filing on February 16, 2023. Nancy Stuart has also filed as director at KalVista Pharmaceuticals, Inc. (KALV).
- How many shares does Nancy Stuart own?
- After the latest filing that states it, Nancy Stuart directly owned 262,596 shares of Concert Pharmaceuticals, Inc. (CNCE). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Nancy Stuart bought or sold stock recently?
- The most recent open-market sale was on February 15, 2023: sold 6,048 shares of Concert Pharmaceuticals, Inc. (CNCE) for $50.4K at an average of $8.33.
- How do I get alerts when Nancy Stuart files?
- Follow Nancy Stuart on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Nancy Stuart (SEC CIK 0001594774). Totals count each trade once, skipping amendments whose original is on file, from Feb 18, 2021 on. View on SEC EDGAR · Get this as JSON